TargetMol

IRI-426

Product Code:
 
TAR-T32192
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T32192-25mg25mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
IRI-426 is a bioactive chemical.
CAS:
103143-78-8
Formula:
C31H47N9O8
Molecular Weight:
673.772
Purity:
0.98
SMILES:
CC(C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O

Documents

References

1. Ohmori S, Kiyohara Y, Ueda K, Kato I, Ohmura T, Iwamoto H, Nakayama K, Nomiyama K, Yoshitake T, Fujishima M. [Hyperinsulinemia and hypertension in an elderly Japanese population--the Hisayama Study]. Nihon Ronen Igakkai Zasshi. 1993 Jul;30(7):595-601. Japanese. PubMed PMID: 8361077. 2. Thapa RK, Choi Y, Jeong JH, Youn YS, Choi HG, Yong CS, Kim JO. Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers. Pharm Res. 2016 Nov;33(11):2815-27. doi: 10.1007/s11095-016-2007-0. Epub 2016 Aug 29. PubMed PMID: 27573575. 3. Mukai M, Torikata C, Iri H, Mikata A, Hanaoka H, Kato K, Kageyama K. Histogenesis of alveolar soft part sarcoma. An immunohistochemical and biochemical study. Am J Surg Pathol. 1986 Mar;10(3):212-8. PubMed PMID: 3513637.